Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.

Forslund A, Zeng Z, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB.

Mol Cancer Res. 2008 Feb;6(2):205-11. doi: 10.1158/1541-7786.MCR-07-0239.

2.

The MDM2 gene amplification database.

Momand J, Jung D, Wilczynski S, Niland J.

Nucleic Acids Res. 1998 Aug 1;26(15):3453-9. Review.

3.

Novel MDM2 p53-independent functions identified through RNA silencing technologies.

Zhang Z, Wang H, Li M, Rayburn E, Agrawal S, Zhang R.

Ann N Y Acad Sci. 2005 Nov;1058:205-14. Review.

PMID:
16394138
4.

[Progress in regulation of activity and stability of ubiquitin protein ligase MDM2].

Nie J, Tian CY.

Yi Chuan. 2009 Oct;31(10):993-8. Review. Chinese.

PMID:
19840920
5.

Shaping genetic alterations in human cancer: the p53 mutation paradigm.

Soussi T, Wiman KG.

Cancer Cell. 2007 Oct;12(4):303-12. Review.

6.

[Advances in study of murine double minute 2/p53 passway with breast cancer].

Ba YH, Li HP.

Beijing Da Xue Xue Bao. 2006 Oct 18;38(5):551-4. Review. Chinese.

7.

[TP53 mutations and molecular epidemiology].

Otsuka K, Ishioka C.

Gan To Kagaku Ryoho. 2007 May;34(5):683-9. Review. Japanese.

PMID:
17496437
8.

Translating p53 into the clinic.

Cheok CF, Verma CS, Baselga J, Lane DP.

Nat Rev Clin Oncol. 2011 Jan;8(1):25-37. doi: 10.1038/nrclinonc.2010.174. Epub 2010 Oct 26. Review.

PMID:
20975744
9.

MDMX: from bench to bedside.

Marine JC, Dyer MA, Jochemsen AG.

J Cell Sci. 2007 Feb 1;120(Pt 3):371-8. Review.

11.

Importance of p53 for cancer onset and therapy.

Haupt S, Haupt Y.

Anticancer Drugs. 2006 Aug;17(7):725-32. Review.

PMID:
16926623
12.

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy.

Rayburn E, Zhang R, He J, Wang H.

Curr Cancer Drug Targets. 2005 Feb;5(1):27-41. Review.

PMID:
15720187
13.

p53 and Mdm2: not all cells are equal.

Coates PJ.

J Pathol. 2007 Dec;213(4):357-9. Review.

PMID:
17973240
14.

Splice variants of MDM2 in oncogenesis.

Rosso M, Okoro DE, Bargonetti J.

Subcell Biochem. 2014;85:247-61. doi: 10.1007/978-94-017-9211-0_14. Review.

PMID:
25201199
15.

The Role of MDM2 Amplification and Overexpression in Tumorigenesis.

Oliner JD, Saiki AY, Caenepeel S.

Cold Spring Harb Perspect Med. 2016 Jun 1;6(6). pii: a026336. doi: 10.1101/cshperspect.a026336. Review.

PMID:
27194168
Items per page

Supplemental Content

Write to the Help Desk